phosphorylethanolamine has been researched along with Bone Loss, Osteoclastic in 1 studies
phosphorylethanolamine: RN given refers to parent cpd; structure
O-phosphoethanolamine : The ethanolamine mono-ester of phosphoric acid, and a metabolite of phospholipid metabolism. This phosphomonoester shows strong structural similarity to the inhibitory neurotransmitter GABA, and is decreased in post-mortem Alzheimer's disease brain.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lundgren, T | 1 |
| Westphal, O | 1 |
| Bolme, P | 1 |
| Modéer, T | 1 |
| Norén, JG | 1 |
1 other study available for phosphorylethanolamine and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Retrospective study of children with hypophosphatasia with reference to dental changes.
Topics: Adolescent; Alkaline Phosphatase; Bone Resorption; Child; Child, Preschool; Dental Cementum; Dentin; | 1991 |